Hans-Peter Biemann - Concepedia

Author

Hans-Peter Biemann

SynZyme Technologies (United States)

Also Known As

H.P. Biemann, Hans-Peter Biemann

Publications

894

Citations

H-Index

Concepts

All Affiliations

SynZyme Technologies (United States)Lawrence Berkeley National Laboratory University of California, Berkeley Gene Therapy Laboratory

About

Hans-Peter Biemann is an author at SynZyme Technologies (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	816
2	Natural Sciences	4	4	480
3	Biochemistry	4	4	362
4	Cell Biology	3	3	468
5	Biomolecular Engineering	1	1	38

Hans-Peter Biemann

Publications

886

Citations

H-Index

Page 1

	Year	Citations
Fas Activation of the p38 Mitogen-Activated Protein Kinase Signalling Pathway Requires ICE/CED-3 Family Proteases Peter Juo, Calvin J. Kuo, Susan E. Reynolds, Molecular and Cellular Biology P38 Kinase ActivityApoptosisImmunologyCell DeathMolecular Biology	1997	284
SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids Paul Mason, Beirong Liang, Lingyun Li, PLoS ONE PathologyCell DeathReference Scd1 InhibitorsCancer BiologyTumor Biology	2012	166
High-resolution Structures of the Ligand Binding Domain of the Wild-type Bacterial Aspartate Receptor Joanne I. Yeh, Hans-Peter Biemann, Gilbert G. Privé, Journal of Molecular Biology Ligand Binding DomainStructural BioinformaticsBiomolecular Structure PredictionMedicineMolecular Biology	1996	152
The three-dimensional structure of the ligand-binding domain of a wild-type bacterial chemotaxis receptor. Structural comparison to the cross-linked mutant forms and conformational changes upon ligand binding Joanne I. Yeh, Hans-Peter Biemann, Jayvardhan Pandit, Journal of Biological Chemistry Protein AssemblyBiomolecular Structure PredictionMolecular BiologyLigand BindingIndividual Subunits	1993	97
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors Yibin Xiang, Bradford Hirth, Gary Asmussen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryPotent Pim-1 InhibitorsMedicineNatural Sciences	2011	61
Attractant- and Disulfide-Induced Conformational Changes in the Ligand Binding Domain of the Chemotaxis Aspartate Receptor: A 19F NMR Study Mark A. Danielson, Hans-Peter Biemann, Daniel E. Koshland, Biochemistry	1994	60
Implications of Promiscuous Pim-1 Kinase Fragment Inhibitor Hydrophobic Interactions for Fragment-Based Drug Design Andrew C. Good, Jinyu Liu, Bradford Hirth, Journal of Medicinal Chemistry Molecular RecognitionMedicinal ChemistryDrug TargetFragment DockingBiochemistry	2012	38
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: Assessment of receptor contribution Beverly A. Teicher, Hans-Peter Biemann, George Vande Woude, International Journal of Oncology Neuroblastoma XenograftsImmunologyTumor Growth DelaysPathologyImmunotherapy	2008	18
An Aspartate/Insulin Receptor Chimera Mitogenically Activates Fibroblasts Hans-Peter Biemann, Stacey L. Harmer, Daniel E. Koshland Journal of Biological Chemistry	1996	10

Page 1